Macrolide-resistant Streptococcus pyogenes in Norway: Population structure and resistance determinants

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1896-1899

  Littauer, P ^a,b   Caugant, D A ^c,d   Sangvik, M ^a,b   Hoiby E A ^c   Sundsfjord, A ^a,b,c   Simonsen, G S ^a,b,c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; MACROLIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONE; DNA SEQUENCE; ERMTR GENE; GENOTYPE; MEFA GENE; NONHUMAN; NORWAY; POPULATION STRUCTURE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ALLELES; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; MACROLIDES; NORWAY; PREVALENCE; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 33646443934     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1896-1899.2006     Document Type: Article

References (40)

1. Albrich, W. C., D. L. Monnet, and S. Harbarth. 2004. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 10:514-517.
2. Alos, J. I., B. Aracil, J. Oteo, and J. L. Gomez-Garces. 2003. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J. Antimicrob. Chemother. 51:333-337.
3. Bergman, M., S. Huikko, M. Pihlajamaki, P. Laippala, E. Palva, P. Huovinen, and H. Seppala. 2004. Effect of macrolide consumption on crythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin. Infect. Dis. 38:1251-1256.
4. Cochetti, I., M. Vecchi, M. Mingoia, E. Tili, M. R. Catania, A. Manzin, P. E. Varaldo, and M. P. Montanari. 2005. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(1). Antimicrob. Agents Chemother. 49:4999-5006.
5. Daly, M. M., S. Doktor, R. Flamm, and D. Shortridge. 2004. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates. J. Clin. Microbiol. 42:3570-3574.
6. Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosti. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.
7. Descheemaeker, P., S. Chapelle, C. Lammens, M. Hauchecorne, M. Wijdooghe, P. Vandamme, M. Ieven, and H. Goossens. 2000. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J. Antimicrob. Chemother. 45:167-173.
8. Detcheva, A., R. R. Facklam, and B. Beall. 2002. Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001. J. Clin. Microbiol. 40:3831-3834.
9. Doherty, N., K. Trzcinski, P. Pickerill, P. Zawadzki, and C. G. Dowson. 2000. Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:2979-2984.
10. Enright, M. C., B. G. Spratt, A. Kalia, J. H. Cross, and D. E. Bessen. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69:2416-2427.
11. Gattringer, R., R. Sauermann, H. Lagler, K. Stich, A. Buxbaum, W. Graninger, and A. Georgopoulos. 2004. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. Int. J. Antimicrob. Agents 24:290-293.
12. Giovanetti, E., A. Brenciani, R. Burioni, and P. E. Varaldo. 2002. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. Antimicrobial. Agents Chemother. 46:3750-3755.
13. Goossens, H., M. Ferech, S. R. Vander, and M. Elseviers. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
14. Kataja, J., P. Huovinen, M. Skurnik, H. Seppala, et al. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52.
15. Kristiansen, B. E., R. A. Sandnes, L. Mortensen, Y. Tveten, and L. Vorland. 2001. The prevalence of antibiotic resistance in bacterial respiratory pathogens from Norway is low. Clin. Microbiol. Infect. 7:682-687.
16. Littauer, P., M. Sangvik, D. A. Caugant, E. A. Hoiby, G. S. Simonsen, and A. Sundsfjord. 2005. Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J. Clin. Microbiol. 43:2125-2132.
17. Martinez, S., A. M. Amoroso, A. Famiglietti, C. de Mier, C. Vay, and G. O. Gutkind. 2004. Genetic and phenotypic characterization of resistance to macrolides in Streptococcus pyogenes from Argentina. Int. J. Antimicrob. Agents 23:95-98.
18. Maxted, W. R., J. P. Widdowson, C. A. Fraser, L. C. Ball, and D. C. Bassett. 1973. The use of the serum opacity reaction in the typing of groupA streptococci. J. Med. Microbiol. 6:83-90.
19. McGeer, A., and D. E. Low. 2003. Is resistance futile? Nat. Med. 9:390-392.
20. McGregor, K. F., and B. G. Spratt. 2005. Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting. J. Clin. Microbiol. 43:1963-1967.
21. McGregor, K. F., B. G. Spratt, A. Kalia, A. Bennett, N. Bilek, B. Beall, and D. E. Bessen. 2004. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J. Bacteriol. 186:4285-4294.
22. Montanari, M. P., I. Cochetti, M. Mingoia, and P. E. Varaldo. 2003. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:2236-2241.
23. Nielsen, H. U., A. M. Hammerum, K. Ekelund, D. Bang, L. V. Pallesen, and N. Frimodt-Moller. 2004. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb. Drug Resist. 10:231-238.
24. NORM/NORM-VET 2002. 2003. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo 2003. ISSN: 1502-2307. [Online.] www.zoonose.no.
25. Olsvik, B., I. Olsen, and F. C. Tenover. 1995. Detection of tet(M) and tet(O) using the polymerase chain reaction in bacteria isolated from patients with periodontal disease. Oral Microbiol. Immunol. 10:87-92.
26. Perez-Trallero, E., J. M. Marimon, M. Montes, B. Orden, and M. de Pablos. 1999. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg. Infect. Dis. 5:235-240.
27. Reinert, R. R., C. Franken, M. van der Linden, R. Lutticken, M. Cil, and A. Al Lahham. 2004. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Int. J. Antimicrob. Agents 24:43-47.
28. Reinert, R. R., R. Lutticken, J. A. Sutcliffe, A. Tait-Kamradt, M. Y. Cil, H. M. Schorn, A. Bryskier, and A. Al Lahham. 2004. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob. Agents Chemother. 48:1369-1373.
29. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
30. Sangvik, M., P. Littauer, G. S. Simonsen, A. Sundsfjord, and K. H. Dahl. 2005. mef(A), mef(E), and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J. Antimicrob. Chemother. 56:841-846.
31. Seppala, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, P. Huovinen, et al. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441-446.
32. Seppala, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
33. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
34. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
35. Syrogiannopoulos, G. A., I. N. Grivea, F. Fitoussi, C. Doit, G. D. Katopodis, E. Bingen, and N. G. Beratis. 2001. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr. Infect. Dis. J. 20:863-868.
36. Szczypa, K., E. Sadowy, R. Izdebski, and W. Hryniewicz. 2004. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J. Antimicrob. Chemother. 54:828-831.
37. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutclifie. 1997. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255.
38. Tait-Kamradt, A., T. Davies, M. Cronan, M. R. Jacobs, P. C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.
39. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585.
40. Weiss, K., J. De Azavedo, C. Restieri, L. A. Galarneau, M. Gourdeau, P. Harvey, J. F. Paradis, K. Salim, and D. E. Low. 2001. Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada. J. Antimicrob. Chemother. 47:345-348.